Key Points
- Charles Jobson, a major shareholder, purchased 15,397 shares of The Joint Corp. at an average price of $8.50 on Feb. 12, increasing his stake to 1,645,294 shares (a ~0.94% increase) valued at roughly $13.98M.
- The stock recently opened at $8.92 and trades below its 50- and 200-day averages (~$9.28–$9.31), with a one-year range of $7.50–$13.47, a market cap of $132.6M and a negative P/E of -148.64.
- Analysts are mixed — the consensus rating is Hold with an average target of $17.00 — while institutional investors control about 76.88% of the company’s shares.
The Joint Corp. (NASDAQ:JYNT - Get Free Report) major shareholder Charles Jobson bought 15,397 shares of the company's stock in a transaction dated Thursday, February 12th. The stock was bought at an average cost of $8.50 per share, for a total transaction of $130,874.50. Following the acquisition, the insider owned 1,645,294 shares of the company's stock, valued at approximately $13,984,999. This trade represents a 0.94% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Major shareholders that own 10% or more of a company's shares are required to disclose their sales and purchases with the SEC.
Joint Price Performance
Shares of NASDAQ JYNT opened at $8.92 on Wednesday. The stock has a fifty day moving average price of $9.28 and a 200 day moving average price of $9.31. The Joint Corp. has a 1-year low of $7.50 and a 1-year high of $13.47. The company has a market cap of $132.60 million, a PE ratio of -148.64 and a beta of 1.35.
Hedge Funds Weigh In On Joint
A number of large investors have recently made changes to their positions in the stock. Deutsche Bank AG boosted its holdings in Joint by 1.8% during the fourth quarter. Deutsche Bank AG now owns 84,745 shares of the company's stock worth $739,000 after buying an additional 1,462 shares in the last quarter. BNP Paribas Financial Markets lifted its position in shares of Joint by 104.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,935 shares of the company's stock valued at $28,000 after acquiring an additional 1,501 shares during the period. Barclays PLC boosted its stake in shares of Joint by 5.3% during the 4th quarter. Barclays PLC now owns 32,235 shares of the company's stock worth $281,000 after acquiring an additional 1,623 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Joint by 25.9% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,244 shares of the company's stock worth $95,000 after acquiring an additional 1,698 shares during the period. Finally, JPMorgan Chase & Co. grew its holdings in shares of Joint by 32.3% in the 2nd quarter. JPMorgan Chase & Co. now owns 7,412 shares of the company's stock worth $86,000 after acquiring an additional 1,810 shares during the period. Hedge funds and other institutional investors own 76.88% of the company's stock.
Wall Street Analyst Weigh In
A number of research analysts have recently issued reports on the stock. Weiss Ratings reiterated a "sell (e+)" rating on shares of Joint in a research note on Thursday, January 22nd. B. Riley Financial lowered Joint from a "buy" rating to a "hold" rating in a report on Friday, November 7th. One analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $17.00.
Check Out Our Latest Report on JYNT
Joint Company Profile
(
Get Free Report)
The Joint Chiropractic, Inc, doing business as Joint (NASDAQ: JYNT), is a franchisor and operator of outpatient chiropractic clinics in the United States. Under its flagship The Joint Chiropractic brand, the company offers membership-based, cash-focused spinal adjustment services designed to promote accessible, routine care for neck and back discomfort. By removing insurance requirements and offering walk-in visits, Joint aims to streamline the patient experience and reduce cost barriers to ongoing chiropractic treatment.
Joint's growth strategy centers on partnering with franchisees to expand its network of clinics.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
